Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Highnoon Laboratories Limited

Market Cap 52.16B 188M 162M 149M 140M 263M 17.7B 265M 1.76B 686M 8.69B 704M 689M 30.06B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 52.16B 188M 162M 149M 140M 263M 17.7B 265M 1.76B 686M 8.69B 704M 689M 30.06B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.53x
Free-Float
50.02%
Yield 2026 *
4.57%
Yield 2027 * 5.28%
1 day-1.38%
1 week+1.60%
Current month+1.50%
1 month+3.36%
3 months+10.96%
6 months-3.94%
Current year-3.72%
1 week 960
Extreme 960
1,039
1 month 929.5
Extreme 929.5
1,039
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 322.1
Extreme 322.1
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.8558
1,241
Manager TitleAgeSince
Chief Executive Officer - 01/04/2015
Chief Executive Officer 63 01/01/1996
Director of Finance/CFO - 01/04/2020
Director TitleAgeSince
Chairman - 07/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.38%+1.60%+3.27%+175.70% 190M
-0.83%-1.77%+41.07%+146.97% 1,001B
-1.28%-2.06%+53.28%+42.31% 566B
-0.47%-1.24%+19.77%+61.19% 393B
+3.82%+2.29%+24.04%+16.53% 326B
+1.09%+1.65%+26.61%+33.19% 276B
+1.42%+0.06%+26.36%+15.68% 277B
+1.87%+0.87%-41.49%-47.26% 193B
-1.50%+2.16%+18.95%+50.93% 188B
-1.70%+3.57%+16.50%+61.90% 158B
Average -0.34%+0.54%+18.84%+55.71% 337.7B
Weighted average by Cap. -0.41%-0.41%+29.52%+66.41%

Financials

2026 *2027 *
Net sales 30.4B 109M 94.31M 86.7M 81.61M 153M 10.32B 155M 1.03B 400M 5.06B 410M 402M 17.52B 34.16B 123M 106M 97.44M 91.71M 172M 11.59B 174M 1.15B 450M 5.69B 461M 451M 19.68B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
17/06/26 984.48 -1.38% 176,738
16/06/26 998.24 +0.73% 38,666
15/06/26 991.04 +2.96% 114,628
12/06/26 962.59 -0.04% 63,602
11/06/26 962.97 -0.20% 11,805
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
984.48PKR
Average target price
1,121.00PKR
Spread / Average Target
+13.87%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!